ArticleFrontiers in pediatrics2026
Metabolic maturity patterns in neonates: dissecting the interactive effects of gestational age and birth weight on metabolic profiles.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Newborn screening (NBS) based on tandem mass spectrometry (MS/MS) is essential for the early identification of inherited metabolic disorders. However, physiological immaturity in preterm and low-birth-weight (LBW) infants frequently alters metabolite concentrations, thereby increasing the risk of false-positive results. Objective: This study aimed to clarify the independent and interactive effects of gestational age (GA) and birth weight (BW) on neonatal amino acid and acylcarnitine profiles, with the goal of improving screening precision in vulnerable populations. Methods: We conducted a retrospective analysis of 147,643 neonates screened in Hunan Province, China. The cohort was stratified into seven GA groups and five BW groups. One-way and two-way analyses of variance (ANOVA), together with principal component analysis (PCA), were used to characterize main effects, interaction effects, and global metabolic clustering. Results: Metabolic profiles followed distinct developmental trajectories. Preterm infants (<37 weeks) showed significantly elevated amino acid concentrations (e.g., tyrosine and arginine) but relative attenuation of long-chain acylcarnitine levels, suggesting an altered balance between protein turnover and fatty acid oxidation. Importantly, significant GA × BW interactions were detected for multiple markers, indicating that the metabolic impact of birth weight varied according to gestational maturity. Conclusion: Neonatal metabolic maturity is shaped by the synergistic interplay between intrauterine duration and fetal growth. The characteristic "high amino acid/low long-chain acylcarnitine" pattern observed in preterm infants, especially in those with lower birth weight, supports the need for individualized reference intervals in newborn screening.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.